Mechelen, Belgium

Sara Bertha Camiel Vrielynck

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Galapagos Nv. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sara Bertha Camiel Vrielynck. Retrieved from https://idiyas.com/inventor/sara-bertha-camiel-vrielynck

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sara Bertha Camiel Vrielynck: Innovator in Pharmaceutical Compositions

Introduction

Sara Bertha Camiel Vrielynck is a notable inventor based in Mechelen, Belgium. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory disorders. Her innovative work has led to the development of a patent that addresses various medical conditions.

Latest Patents

Sara holds a patent for "Pharmaceutical compositions for the treatment of inflammatory disorders." This invention discloses pharmaceutical compositions that include a compound useful in the prophylaxis and treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergies, transplant rejection, and diseases associated with cartilage homeostasis. The patent highlights her commitment to advancing medical science and improving patient outcomes.

Career Highlights

Sara is currently associated with Galapagos NV, a company known for its focus on innovative medicines. Her role at Galapagos NV allows her to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Sara has worked alongside notable colleagues, including Marc Maurice Germain De Weer and Nicolas Luc Sabourault. Their combined expertise fosters a collaborative environment that enhances the development of effective pharmaceutical solutions.

Conclusion

Sara Bertha Camiel Vrielynck is a pioneering inventor whose work in pharmaceutical compositions has the potential to transform the treatment of inflammatory disorders. Her dedication to innovation and collaboration continues to make a significant impact in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…